Streetbeat News

Price Targets

CLH

Baird analyst David Manthey has maintained an Outperform rating on Clean Harbors (NYSE:CLH) and increased the price target from $192 to $235.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:24 am

APG

Baird analyst Andrew Wittmann maintains an Outperform rating on APi Group Corporation (APG) and raises the price target from $39 to $43.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:21 am

NFLX

Macquarie analyst Tim Nollen maintains an Outperform rating on Netflix (NASDAQ:NFLX) and raises the price target from $595 to $685.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:18 am

SMCI

Loop Capital analyst Ananda Baruah has maintained a Buy rating on Super Micro Computer (NASDAQ:SMCI) and increased the price target from $600 to $1500.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:16 am

LAB

TD Cowen analyst Daniel Brennan initiates coverage on Standard BioTools (NASDAQ:LAB) with a Buy rating and a price target of $3.5.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:15 am

VALE

Barclays analyst Amos Fletcher maintains an Overweight rating on Vale (NYSE:VALE) and raises the price target from $16 to $17.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:12 am

SCHW

Barclays analyst Benjamin Budish maintains an Equal-Weight rating on Charles Schwab (SCHW) and raises the price target from $74 to $75.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:10 am

AL

Barclays analyst Mark Devries maintains an Overweight rating on Air Lease (NYSE:AL) and raises the price target from $48 to $55.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:09 am

TSN

Barclays analyst Benjamin Theurer upgraded Tyson Foods (NYSE:TSN) from Underweight to Overweight and increased the price target from $53 to $69, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:08 am

UBX

HC Wainwright & Co. analyst Andrew Fein maintains a Buy rating on Unity Biotechnology (NASDAQ:UBX) but lowers the price target from $10 to $8.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:05 am